Gymnastics legend Nadia Comaneci, celebrated for her historic perfect 10s, has voiced her stance on transgender athletes in women's sports, stating, “women’s sports are for women.” Her comments, ...

Thanks to her effort, dedication, and beauty, the Paraguayan native was named first runner-up behind Harnaaz Sandhu, who succeeded Andrea Meza. Miss Paraguay, Nadia Ferreira, poses in the evening gown ...

Cosentyx (secukinumab) comes as a subcutaneous injection under the skin or an intravenous (IV) infusion into a vein. Doctors may prescribe it to treat plaque psoriasis, psoriatic arthritis, and other ...

Novartis has announced that its treatment for polymyalgia rheumatica (PMR), Cosentyx (secukinumab), achieved all primary and secondary endpoints in the phase 3 REPLENISH trial. REPLENISH is a global, ...

Polymyalgia rheumatica is the second most common inflammatory rheumatic disease in adults aged 50 years and older, typically characterized by acute pain and stiffness in the shoulders, neck, and hips.

Novartis said that its immunology drug Cosentyx met the primary target and all secondary ones in a late-stage trial for the treatment of patients with inflammatory disease polymyalgia rheumatica.

(RTTNews) - Novartis (NVS,NOVN.SW) announced that its interleukin-17A inhibitor Cosentyx (secukinumab) met the primary and all secondary endpoints in the Phase III REPLENISH trial. The study evaluated ...

Cosentyx, an autoimmune disease therapy that cost the healthcare industry $7.7 billion in 2024, will be offered at a 55% discount beginning in November. The drug’s manufacturer, Novartis, said Sept.

Novartis NOVN0.17%increase; green up pointing triangle said it is launching a direct-to-patient platform in the U.S. to sell a discounted version of its Cosentyx drug, the latest big pharma company to ...

At the 2025 Emmy Awards, Walton Goggins is nominated for his scene-stealing performance as Rick on The White Lotus. As season three aired, rumors swirled about what happened behind-the-scenes between ...

The Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) injections for treating various inflammatory conditions in adults and, in some cases, children. Cosentyx may treat moderate ...